arrow
R

Rosa Prato

University of Foggia
H指数:34
被引数:3,590

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and immunogenicity of 4CMenB and MenACWY-CRM meningococcal vaccines when administered concomitantly in healthy adolescents: A phase 3b, randomized, observer-blind study

4CMenB和MenACWY-CRM脑膜炎球菌疫苗在健康青少年中同时接种时的安全性和免疫原性:一项3b期、随机、观察者盲法研究

2026-06-090
OA
Real-World Effectiveness of Nirsevimab in Preventing RSV Hospitalizations: Evidence of Protection in Southern Italian Infants, 2024–2025

Nirsevimab在预防RSV住院治疗中的真实世界有效性:2024–2025年意大利南部婴儿的保护证据

2025-10-300
OAAI
Six-month follow-up of antibody response to bivalent mRNA SARS-CoV-2 vaccine booster in healthcare workers

六个月随访:医疗保健工作者对二价mRNA SARS-CoV-2疫苗加强针的抗体反应

Vaccine
IF3.5
2025-07-300
OA
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition

从2023年10月到2024年4月在意大利传播的JN.1变异: 遗传多样性和免疫识别

2025-02-280
OAAI
Delirium Incidence and Predictors in SARS-CoV-2 Vaccinated Residents in Long-Term Care Facilities (LTCF): Insights from the GeroCovid Vax Study
2024-11-010
OAAI
A 12-month follow-up of the immune response to SARS-CoV-2 primary vaccination: evidence from a real-world study

对SARS-CoV-2初次接种疫苗的免疫反应进行12个月的随访: 来自现实世界研究的证据

2023-11-201
OAAI
Four-Component Recombinant Protein-Based Vaccine Effectiveness Against Serogroup B Meningococcal Disease in Italy
2023-08-188
OAAI
Prevalence of Pneumococcal Serotypes in Community-Acquired Pneumonia among Older Adults in Italy: A Multicenter Cohort Study

意大利老年人社区获得性肺炎肺炎球菌血清型患病率: 一项多中心队列研究

2022-12-267
OAAI
Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study
2022-10-3120
OAAI